Page 168 - Haematologica May 2020
P. 168

V. Agnusdei et al. References
1. Oliveira ML, Akkapeddi P, Alcobia I, et al. From the outside, from within: Biological and therapeutic relevance of signal transduc- tion in T-cell acute lymphoblastic leukemia. Cell Signal. 2017;38:10-25.
2. Pierro J, Hogan LE, Bhatla T, Carroll WL. New targeted therapies for relapsed pedi- atric acute lymphoblastic leukemia. Expert Rev Anticancer Ther. 2017;17(8):725-736.
3. Pui CH, Yang JJ, Hunger SP, et al. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. J Clin Oncol. 2015;33(27):2938-2948.
4. Aifantis I, Raetz E, Buonamici S. Molecular pathogenesis of T-cell leukaemia and lym- phoma. Nat Rev Immunol. 2008;8(5):380- 390.
5. Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306(5694):269-271.
6. Sulis ML, Williams O, Palomero T, et al. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. Blood. 2008; 112(3):733-740.
7. O'Neil J, Grim J, Strack P, et al. FBW7 muta- tions in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med. 2007;204(8):1813-1824.
8. Platonova N, Lesma E, Basile A, et al. Targeting Notch as a therapeutic approach for human malignancies. Curr Pharm Des. 2017;23(1):108-134.
9. Agnusdei V, Minuzzo S, Frasson C, et al. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts. Leukemia. 2014;28(2):278-288.
10. Hales EC, Taub JW, Matherly LH. New insights into Notch1 regulation of the PI3K- AKT-mTOR1 signaling axis: targeted thera- py of gamma-secretase inhibitor resistant T- cell acute lymphoblastic leukemia. Cell Signal. 2014;26(1):149-161.
11. Pinazza M, Borga C, Agnusdei V, et al. An immediate transcriptional signature associ- ated with response to the histone deacety- lase inhibitor Givinostat in T acute lym- phoblastic leukemia xenografts. Cell Death Dis. 2016;6:e2047.
12. Pinazza M, Ghisi M, Minuzzo S, et al. Histone deacetylase 6 controls Notch3 traf-
ficking and degradation in T-cell acute lym- phoblastic leukemia cells. Oncogene. 2018;37(28):3839-3851.
13. Palomero T, Sulis ML, Cortina M, et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med. 2007;13(10):1203-1210.
14. Brown KK, Toker A. The phosphoinositide 3-kinase pathway and therapy resistance in cancer. F1000Prime Rep. 2015;7:13.
Notch and its ligands. Curr Top Dev Biol.
2010;92:165-200.
25. Fortini ME, Bilder D. Endocytic regulation of
2009;19(4):323-328.
26. Drzazga A, Sowińska A, Koziołkiewicz M.
Lysophosphatidylcholine and lysophos- phatidylinosiol--novel promissing signaling molecules and their possible therapeutic activity. Acta Pol Pharm. 2014;71(6):887-
   15. Zeng Z, Shi YX, Tsao T, et al. Targeting of 899.
mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment. Blood. 2012; 120(13):2679-2689.
16. Gordon WR, Roy M, Vardar-Ulu D, et al. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. Blood. 2009;113(18):4381-4390.
17. Breit S, Stanulla M, Flohr T, et al. Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood. 2006;108(4):1151-1157.
18. Pazarentzos E, Bivona TG. Adaptive stress signaling in targeted cancer therapy resist- ance. Oncogene. 2015;34(45):5599-5606.
27. Furse S, de Kroon AI. Phosphatidylcholine's functions beyond that of a membrane brick. Mol Membr Biol. 2015;32(4):117-119.
28. Ridgway ND. The role of phosphatidyl- choline and choline metabolites to cell pro- liferation and survival. Crit Rev Biochem Mol Biol. 2013;48(1):20-38.
29. Ryland LK, Fox TE, Liu X, Loughran TP, Kester M. Dysregulation of sphingolipid metabolism in cancer. Cancer Biol Ther. 2011;11(2):138-149.
30. Herranz D, Ambesi-Impiombato A, Sudderth J, et al. Metabolic reprogramming induces resistance to anti-NOTCH1 thera- pies in T cell acute lymphoblastic leukemia. Nat Med. 2015;21(10):1182-1189.
31. Hori K, Sen A, Kirchhausen T, Artavanis- Tsakonas S. Regulation of ligand-indepen- dent Notch signal through intracellular traf- ficking. Commun Integr Biol. 2012;5(4):374-
19. Clappier E, Gerby B, Sigaux F, et al. Clonal
selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of 376.
malignancy at relapse. J Exp Med.
2011;208(4):653-661.
20. Poglio S, Lewandowski D, Calvo J, et al.
Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia. Oncotarget. 2016;7(27):41599-41611.
21. Rysman E, Brusselmans K, Scheys K, et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res. 2010;70(20):8117-8126.
22. Weber U, Eroglu C, Mlodzik M. Phospholipid membrane composition affects EGF receptor and Notch signaling through effects on endocytosis during Drosophila development. Dev Cell. 2003; 5(4):559-570.
23. Fortini ME. Notch signaling: the core path- way and its posttranslational regulation. Dev Cell. 2009;16(5):633-647.
24. Yamamoto S, Charng WL, Bellen HJ. Endocytosis and intracellular trafficking of
32. Kanwar R, Fortini ME. Notch signaling: a different sort makes the cut. Curr Biol. 2004; 14(24):R1043-1045.
33. Hori K, Fostier M, Ito M, et al. Drosophila deltex mediates suppressor of Hairless-inde- pendent and late-endosomal activation of Notch signaling. Development. 2004; 131(22):5527-5537.
34. Hori K, Sen A, Kirchhausen T, Artavanis- Tsakonas S. Synergy between the ESCRT-III complex and Deltex defines a ligand-inde- pendent Notch signal. J Cell Biol. 2011; 195(6):1005-1015.
35. Wilkin M, Tongngok P, Gensch N, et al. Drosophila HOPS and AP-3 complex genes are required for a Deltex-regulated activa- tion of notch in the endosomal trafficking pathway. Dev Cell. 2008;15(5):762-772.
36. Griffith M, Spies NC, Krysiak K, et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nat Genet. 2017;49(2): 170-174.
Notch signaling. Curr Opin Genet Dev.
 1328
  haematologica | 2020; 105(5)
   
















































   166   167   168   169   170